- Home
- ICCM vs RAND Comparison
ICCM vs RAND Comparison
Compare ICCM & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- RAND
- Stock Information
- Founded
- ICCM 2006
- RAND 1969
- Country
- ICCM Israel
- RAND United States
- Employees
- ICCM N/A
- RAND N/A
- Industry
- ICCM
- RAND Finance: Consumer Services
- Sector
- ICCM
- RAND Finance
- Exchange
- ICCM Nasdaq
- RAND Nasdaq
- Market Cap
- ICCM 70.1M
- RAND 52.9M
- IPO Year
- ICCM N/A
- RAND N/A
- Fundamental
- Price
- ICCM $1.03
- RAND $18.22
- Analyst Decision
- ICCM Strong Buy
- RAND
- Analyst Count
- ICCM 1
- RAND 0
- Target Price
- ICCM $2.50
- RAND N/A
- AVG Volume (30 Days)
- ICCM 196.6K
- RAND 5.8K
- Earning Date
- ICCM 05-27-2025
- RAND 05-05-2025
- Dividend Yield
- ICCM N/A
- RAND 6.37%
- EPS Growth
- ICCM N/A
- RAND 39.63
- EPS
- ICCM N/A
- RAND 3.11
- Revenue
- ICCM $3,291,000.00
- RAND $8,499,970.00
- Revenue This Year
- ICCM $97.02
- RAND N/A
- Revenue Next Year
- ICCM $212.86
- RAND N/A
- P/E Ratio
- ICCM N/A
- RAND $5.86
- Revenue Growth
- ICCM 1.92
- RAND 12.52
- 52 Week Low
- ICCM $0.48
- RAND $13.94
- 52 Week High
- ICCM $1.66
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- ICCM 37.29
- RAND 42.11
- Support Level
- ICCM $1.00
- RAND $18.00
- Resistance Level
- ICCM $1.34
- RAND $19.70
- Average True Range (ATR)
- ICCM 0.08
- RAND 0.81
- MACD
- ICCM -0.01
- RAND -0.01
- Stochastic Oscillator
- ICCM 8.82
- RAND 7.33
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.